Novavax stock surges after the vaccine maker signs a $1.2 billion licensing deal with France’s Sanofi, guidance from Akamai Technologies misses estimates, and Sweetgreen soars after the salad chain boosts its full-year revenue outlook.
Shares of web content delivery and security company Akamai (NASDAQ:AKAM) fell 11.2% in the morning session after the company reported first-quarter earnings results. Although its EPS beat Wall Street's estimates, its full-year revenue guidance missed analysts' expectations, sending the stock down. Company outlooks have been the big focus this earnings season. On the bright side, the Board authorized a new three-year, $2.0 billion share repurchase program. Overall, the results could have been bet
Robust Growth in Security and Compute Solutions Drives Performance